Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.
about
Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@en
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@nl
type
label
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@en
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@nl
prefLabel
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@en
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@nl
P2093
P2860
P356
P1433
P1476
Targeting hyperactivated DNA-P ...... suppression of AKT signaling.
@en
P2093
Chunjiang Yu
Haoran Wang
Mingshan Zhang
Qimin Zhan
Yanming Qu
Yongmei Song
Zhihua Zhang
P2860
P304
55555-55571
P356
10.18632/ONCOTARGET.10864
P407
P577
2016-07-27T00:00:00Z